Your browser doesn't support javascript.
loading
Cumulative risks of colorectal cancer in Han Chinese patients with Lynch syndrome in Taiwan.
Kamiza, Abram Bunya; Wang, Wen-Chang; You, Jeng-Fu; Tang, Reiping; Chien, Huei-Tzu; Lai, Chih-Hsiung; Chiu, Li-Ling; Lo, Tsai-Ping; Hung, Kuan-Yi; Hsiung, Chao A; Yeh, Chih-Ching.
Afiliação
  • Kamiza AB; School of Public Health, College of Public Health, Taipei Medical University, 250 Wu-Hsing Street, Taipei, Taiwan.
  • Wang WC; The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • You JF; Colorectal Section, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Tang R; School of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Chien HT; Colorectal Section, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Lai CH; School of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Chiu LL; Department of Nutrition and Health Sciences, Chang Gung University of Science and Technology, Taoyuan, Taiwan.
  • Lo TP; Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan, Taiwan.
  • Hung KY; Department of Public Health, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Hsiung CA; Department of Nutrition and Health Sciences, Chang Gung University of Science and Technology, Taoyuan, Taiwan.
  • Yeh CC; Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan.
Sci Rep ; 11(1): 8899, 2021 04 26.
Article em En | MEDLINE | ID: mdl-33903664
ABSTRACT
Patients with Lynch syndrome have a high risk of colorectal cancer (CRC). In this study, we estimated the age- and sex-specific cumulative risks of CRC in Han Chinese patients with Lynch syndrome caused by the pathogenic germline mutations in MLH1 or MSH2 in Taiwan. Based on 321 mutation carriers and 419 non-mutation carriers from 75 pedigrees collected in an Amsterdam criteria family registry in Taiwan, the age- and sex-specific cumulative risks of CRC in male carriers of mutation in MLH1 and MSH2 at the age of 70 years were 60.3% (95% confidence interval (CI) = 31.1%-89.9%) and 76.7% (95% CI = 37.2%-99.0%), respectively. For females, the cumulative risks of CRC at the age of 70 were estimated to be 30.6% (95% CI = 14.3%-57.7%) and 49.3% (95% CI = 21.9%-84.5%) in the carriers of MLH1 and MSH2 germline mutations, respectively. In conclusion, the cumulative risks of CRC at the age of 70 in the Han Chinese patients is higher in mutation carriers than non-mutation carriers and male mutation carriers have a higher cumulative risk of developing CRC than the female mutation carriers.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Mutação em Linhagem Germinativa / Proteína 2 Homóloga a MutS / Proteínas MutL / Proteínas de Neoplasias Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Mutação em Linhagem Germinativa / Proteína 2 Homóloga a MutS / Proteínas MutL / Proteínas de Neoplasias Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article